Radiotherapy, tumor mutational burden, and immune checkpoint inhibitors: time to do the math.

Giordano, Frank A; Veldwijk, Marlon R; Herskind, Carsten; Wenz, Frederik

Giordano, Frank A; Veldwijk, Marlon R; Herskind, Carsten; Wenz, Frederik.

Afiliación

Giordano FA; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. frank.giordano@umm.de.
Veldwijk MR; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Herskind C; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Wenz F; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Strahlenther Onkol ; 194(10): 873-875, 2018 10.

Article en En | MEDLINE | ID: mdl-30030581

Asunto(s)

Mutación; Carga Tumoral; Humanos; Neoplasias

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carga Tumoral / Mutación Límite: Humans Idioma: En Revista: Strahlenther Onkol Asunto de la revista: NEOPLASIAS / RADIOTERAPIA Año: 2018 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google